Wong RJ, Singal AK. Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014–2019. JAMA Network Open. 2020;3(2):e1920294-e.
Franz CC, Hildbrand C, Born C, Egger S, Rätz Bravo AE, Krähenbühl S. Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations. Eur J Clin Pharmacol. 2013;69(8):1565–73.
US Department of Health and Human Services, Food and Drug Administration. Guidance for industry-pharmacokinetics in patients with impaired hepatic function: study design, data analysis, and impact on dosing and labeling. Rockville, MD, USA. 2003.
Tang HS, Hu OY. Assessment of liver function using a novel galactose single point method. Digestion. 1992;52(3–4):222–31.
Keiding S. Galactose clearance measurements and liver blood flow. Gastroenterology. 1988;94(2):477–81.
Pang KS, Rowland M. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm. 1977;5(6):625–53.
Pang KS, Rowland M. Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liver in situ preparation. J Pharmacokinet Biopharm. 1977;5(6):655–80.
Keiding S, Johansen S, Winkler K, Tonnesen K, Tygstrup N. Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig liver. Am J Physiol. 1976;230(5):1302–13.
Takahashi H, Shigefuku R, Yoshida Y, Ikeda H, Matsunaga K, Matsumoto N, et al. Correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis. World J Gastroenterol. 2014;20(45):17065–74.
Dupont S, Schiffer ERC, White MJ, Diaper JRA, Licker MJ, Masouye PC. Changes in hepatic blood flow and liver function during closed abdominal hyperthermic intraperitoneal chemotherapy following cytoreduction surgery. Gastroenterol Res Pract. 2018;2018:8063097.
Cohn JN, Khatri IM, Groszmann RJ, Kotelanski B. Hepatic blood flow in alcoholic liver disease measured by an indicator dilution technic. Am J Med. 1972;53(6):704–14.
Sun H, Zhao H. Drug elimination and hepatic clearance. In: Shargel L, Yu A, editors. Applied biopharmaceutics & pharmacokinetics. 7th ed. McGraw-Hill/Appleton & Lange, USA. 2015.
Ranek L, Lindskov J, Tygstrup N, Winkler K. Splanchnic galactose uptake in patients with cirrhosis following single injection. Clin Physiol (Oxford, England). 1983;3(2):173–8.
Hu OY, Hu TM, Tang HS. Determination of galactose in human blood by high-performance liquid chromatography: comparison with an enzymatic method and application to the pharmacokinetic study of galactose in patients with liver dysfunction. J Pharm Sci. 1995;84(2):231–5.
Sun L, Bulter T, Alcalde M, Petrounia IP, Arnold FH. Modification of galactose oxidase to introduce glucose 6-oxidase activity. Chembiochem Eur J Chem Biol. 2002;3(8):781–3.
Tang Z, Louie RF, Lee JH, Lee DM, Miller EE, Kost GJ. Oxygen effects on glucose meter measurements with glucose dehydrogenase- and oxidase-based test strips for point-of-care testing. Crit Care Med. 2001;29(5):1062–70.
Cuatrecasas P, Segal S. Mammalian galactose dehydrogenase. II. Properties, substrate specificity, and developmental changes. J Biol Chem. 1966;241(24):5910–8.
Fingerhut R, Torresani T. Determination of total galactose from dried blood spots—extensive assay evaluation of a CE-marked test-kit. J Anal Sci Methods Instrum. 2013;03:163–6.
Sun H, Zhao H. Drug elimination and hepatic clearance. In: Shargel L, Yu A, editors. Applied biopharmaceutics and pharmacokinetics. 4th ed. United Kingdom: Prentice-Hall International, Inc.; 1999. p. 566.
Curry SH, Whelpton R. Drug disposition and pharmacokinetics: from principles to applications. 2nd ed. USA: WILEY-BLACKWELL; 2010.